ID: MRFR/LS/0220-HCRR | July, 2017 | Region: Global | 115 pages | Half-Cooked Research Reports
Protein Engineering Market Research Report, By Type (Instruments, Reagent) By End users (Pharmaceutical, Bio-technology) By Applications (Environment, Medical) By Methods (Rational Protein Design, Directed Evolution)- Global Forecast to 2024
About Protein Engineering:
Protein engineering is the designing and construction of new proteins by modifying amino acid sequences to produce enzymes & desired properties or the synthesis of protein with particular structure. It is an important technology that increases our basic understanding of how enzymes function and have evolved, and it is the key method of improving enzyme properties for applications in pharmaceuticals, green chemistry and biofuels.
The objectives of Protein engineering is to create an enzyme which is superior in its properties to produce high value chemicals in large quantities, and to produce biological compounds which includes synthetic peptide, storage protein and synthetic drugs which will be superior to normal one.
Protein Engineering Application:
To improve the properties such as thermo stability, specificity and catalytic efficiency in food and detergent market engineering is been used. Food industry makes use of a variety of food-processing enzymes, such as amylases and lipases, the properties of which are improved using recombinant DNA technology and protein engineering. Also it is beneficial to reduce the toxic compound and to improve the environmental applications, such as the use of enzymes in waste management and pollution control. The study of cancer treatment is one of the major interest areas in medical under protein engineering. Recently, the term “modular protein engineering” has been introduced for emerging cancer therapies. It is also giving useful inputs for antibiotics.
Protein engineering applications cover a broad range which also includes biocatalysts for food industry, and nanotechnology industry.
High cost of tools & instruments used and untrained personnel is the main restraints of this market.
Protein engineering market segmentation:
The protein engineering market is growing on rapid basis. The growth factors includes increased preference of protein drugs over non-protein drugs, reduction of time and cost for drug discovery, and high growth rate of lifestyle diseases.
The protein engineering market segmented into types, method, applications and its end-users.
Protein engineering market by types includes: Instrument, Reagents and Services & Software.
Protein engineering market by methods includes: Rational protein design and directed evolution.
Protein engineering market by applications includes: Food and detergent industries, environment applications, medical applications, biopolymer production, and Nano biotechnology.
Protein engineering market by End users includes: Academic research institutes, pharmaceuticals and bio-technology companies and contract engineering organizations.
Protein engineering market regional analysis:
The regional analysis consists of North America, Europe, and Asian market. The Protein engineering market is been growing with an approximate rate of 50% worldwide.
The market segments of North America include tissue engineering, cell culture, protein engineering, biomaterials and micro-reactor. North America is leading in Protein engineering market followed by Europe and Asia because of the rising prevalence of lifestyle associated diseases and increasing adoption of protein based drugs in the region. Governments of the U.S., Canada, and Brazil have been highly supportive of advancements in protein engineering, creating a favorable regulatory environment for companies in the North American market.
Asian Countries such as India, china, Japan are showing good growth in this market in upcoming years. The growth factors for the protein engineering market in these countries are the large pool of patients, increasing health care awareness, increasing health care expenditure, rising government initiatives, and rising funding for drug discovery in the region.
Protein engineering market major players:
The major players in this market are: Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).
The reports also covers brief analysis of Geographical Region includes:
o Rest of Western Europe
o Rest of Asia
o New Zealand
Every report of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.
Table of Contents
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1.1 Increasing health care awareness
4.1.2 Increasing health care expenditure
4.1.3 Rising funding for drug discovery
4.2.1 Higher financials inputs for R&D in protein engineering
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6 Global Protein Engineering market, By type
7. Global Protein Engineering market by application
8. Global Protein Engineering market by methods
8.1 Rational Protein Design
8.2 Directed Evolution
9. Global Protein Engineering market by region
9.2 North America
9.3.1 Western Europe
22.214.171.124 Rest of Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.4 Republic of Korea
9.4.6 Rest of Asia
9.5 Middle East and Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.4 Rest of Middle East and Africa
10 Competitive Landscape
10.1 Cost of treatment
10.2 Production Capacity of Major Players
11 Company Profile
11.1 Agilent Technologies
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2.2 Product/Business Segment Overview
11.2.3 Financial Updates
11.2.4 Key Developments
11.3 Bio-Rad Laboratories Inc.
11.3.2 Product/Business Segment Overview
11.3.3 Financial Updates
11.4 Bruker Corp.
11.4.2 Product/Business Segment Overview
11.4.3 Financial Updates
11.4.4 Key Development
11.5 GE Healthcare
11.5.2 Product/Business Segment Overview
11.5.3 Financial Updates
11.5.4 Key Developments
11.6 Perkin Elmer
11.6.2 Product/Business Segment Overview
11.6.3 Financial Updates
11.6.4 Key Developments
11.7 Sigma-Aldrich Corp.
11.7.2 Product/Business Segment Overview
11.7.3 Financial Updates
11.7.4 Key Developments